<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font18 { font-size : 18; } .font19 { font-size : 19; } .font23 { font-size : 23; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">vaccine </span>
   <span class="font23">Mtb </span>
   <span class="font19">BCG </span>
   <span class="font18">al.: </span>
   <span class="font15">vaccines </span>
   <span class="font15">development </span>
   <span class="font15">infection </span>
   <span class="font15">tuberculosis </span>
   <span class="font14">clinical </span>
   <span class="font14">immune </span>
   <span class="font14">challenge </span>
   <span class="font14">responses </span>
   <span class="font13">protection </span>
   <span class="font13">Mycobacterium </span>
   <span class="font13">efficacy </span>
   <span class="font13">new </span>
   <span class="font13">vaccination </span>
   <span class="font13">disease </span>
   <span class="font13">human </span>
   <span class="font13">phase </span>
   <span class="font13">T-cell </span>
   <span class="font12">study </span>
   <span class="font12">important </span>
   <span class="font12">including </span>
   <span class="font12">studies </span>
   <span class="font12">potential </span>
   <span class="font12">Vaccine </span>
   <span class="font12">active </span>
   <span class="font12">following </span>
   <span class="font12">response </span>
   <span class="font12">persons </span>
   <span class="font12">trial </span>
   <span class="font12">administered </span>
   <span class="font12">animal </span>
   <span class="font12">immunity </span>
   <span class="font12">immunogenicity </span>
   <span class="font12">model </span>
   <span class="font12">control </span>
   <span class="font12">safety </span>
   <span class="font12">T-cells </span>
   <span class="font11">effect </span>
   <span class="font11">models </span>
   <span class="font11">adults </span>
   <span class="font11">antigens </span>
   <span class="font11">candidate </span>
   <span class="font11">cells </span>
   <span class="font11">demonstrated </span>
   <span class="font11">develop </span>
   <span class="font11">global </span>
   <span class="font11">trials </span>
   <span class="font11">TB. </span>
   <span class="font11">candidates </span>
   <span class="font11">developing </span>
   <span class="font11">include </span>
   <span class="font11">need </span>
   <span class="font11">support </span>
   <span class="font11">Tuberculosis </span>
   <span class="font11">administration </span>
   <span class="font11">given </span>
   <span class="font11">infants </span>
   <span class="font11">pulmonary </span>
   <span class="font11">critical </span>
   <span class="font11">role </span>
   <span class="font11">TB, </span>
   <span class="font11">individuals </span>
   <span class="font11">treatment </span>
   <span class="font11">South </span>
   <span class="font11">adolescents </span>
   <span class="font11">antibodies </span>
   <span class="font11">health </span>
   <span class="font11">impact </span>
   <span class="font11">infected </span>
   <span class="font11">mice </span>
   <span class="font11">natural </span>
   <span class="font11">prevention </span>
   <span class="font11">{border-style </span>
   <span class="font11">Additionally, </span>
   <span class="font11">compared </span>
   <span class="font11">developed </span>
   <span class="font11">greater </span>
   <span class="font11">strategy </span>
   <span class="font11">use </span>
   <span class="font11">cell </span>
   <span class="font11">provide </span>
   <span class="font11">px;} </span>
   <span class="font11">vaccinated </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">ability </span>
   <span class="font11">based </span>
   <span class="font11">degree </span>
   <span class="font11">effective </span>
   <span class="font11">however, </span>
   <span class="font11">protective </span>
   <span class="font11">represents </span>
   <span class="font11">research </span>
   <span class="font11">results </span>
   <span class="font11">rhesus </span>
   <span class="font11">antigen </span>
   <span class="font11">data </span>
   <span class="font11">demonstrate </span>
   <span class="font11">efforts </span>
   <span class="font11">innate </span>
   <span class="font11">CHIM </span>
   <span class="font11">Immunol.;():–. </span>
   <span class="font11">Med.;():–. </span>
   <span class="font11">attenuated </span>
   <span class="font11">cost </span>
   <span class="font11">currently </span>
   <span class="font11">experiments </span>
   <span class="font11">major </span>
   <span class="font11">novel </span>
   <span class="font11">represent </span>
   <span class="font11">risk </span>
   <span class="font11">route </span>
   <span class="font11">used </span>
   <span class="font11">H:IC </span>
   <span class="font11">MTBVAC </span>
   <span class="font11">assessing </span>
   <span class="font11">associated </span>
   <span class="font11">cases </span>
   <span class="font11">controlling </span>
   <span class="font11">different </span>
   <span class="font11">exposure </span>
   <span class="font11">immunological </span>
   <span class="font11">memory </span>
   <span class="font11">patients </span>
   <span class="font11">preventing </span>
   <span class="font11">public </span>
   <span class="font11">small </span>
   <span class="font11">target </span>
   <span class="font11">vaccine, </span>
   <span class="font10">PoD </span>
   <span class="font10">VPM </span>
   <span class="font10">antibody </span>
   <span class="font10">approach </span>
   <span class="font10">assess </span>
   <span class="font10">development. </span>
   <span class="font10">drug </span>
   <span class="font10">expressed </span>
   <span class="font10">improved </span>
   <span class="font10">permit </span>
   <span class="font10">stage </span>
   <span class="font10">survival </span>
   <span class="font10">utilizing </span>
   <span class="font10">Accordingly, </span>
   <span class="font10">BCG, </span>
   <span class="font10">USA); </span>
   <span class="font10">assessed </span>
   <span class="font10">capable </span>
   <span class="font10">discovery </span>
   <span class="font10">disease. </span>
   <span class="font10">duration </span>
   <span class="font10">future </span>
   <span class="font10">high </span>
   <span class="font10">humans </span>
   <span class="font10">lungs </span>
   <span class="font10">provides </span>
   <span class="font10">responses, </span>
   <span class="font10">result </span>
   <span class="font10">African </span>
   <span class="font10">PoR </span>
   <span class="font10">Vaccines </span>
   <span class="font10">approaches </span>
   <span class="font10">better </span>
   <span class="font10">controlled </span>
   <span class="font10">criteria </span>
   <span class="font10">disease, </span>
   <span class="font10">early </span>
   <span class="font10">generate </span>
   <span class="font10">healthy </span>
   <span class="font10">immunization </span>
   <span class="font10">information </span>
   <span class="font10">lung </span>
   <span class="font10">mouse </span>
   <span class="font10">possible </span>
   <span class="font10">prevent </span>
   <span class="font10">suggest </span>
   <span class="font10">systems </span>
   <span class="font10">(NCT). </span>
   <span class="font10">Dis.;():–. </span>
   <span class="font10">LTBI </span>
   <span class="font10">Partnership </span>
   <span class="font10">approximately </span>
   <span class="font10">assessments </span>
   <span class="font10">available </span>
   <span class="font10">bacterial </span>
   <span class="font10">drug-resistant </span>
   <span class="font10">effort </span>
   <span class="font10">extent </span>
   <span class="font10">highly </span>
   <span class="font10">identified </span>
   <span class="font10">improve </span>
   <span class="font10">infants, </span>
   <span class="font10">initial </span>
   <span class="font10">mucosal </span>
   <span class="font10">opportunity </span>
   <span class="font10">protein </span>
   <span class="font10">rate </span>
   <span class="font10">response, </span>
   <span class="font10">section </span>
   <span class="font10">specific </span>
   <span class="font10">strains </span>
   <span class="font10">suggesting </span>
   <span class="font10">time </span>
   <span class="font10">trials. </span>
   <span class="font10">vaccines. </span>
   <span class="font10">BMGF </span>
   <span class="font10">Global </span>
   <span class="font10">Mtb. </span>
   <span class="font10">NHP </span>
   <span class="font10">NHPs </span>
   <span class="font10">New </span>
   <span class="font10">TST </span>
   <span class="font10">adults, </span>
   <span class="font10">cells, </span>
   <span class="font10">conversion </span>
   <span class="font10">days </span>
   <span class="font10">delivery </span>
   <span class="font10">epidemic </span>
   <span class="font10">evidence </span>
   <span class="font10">experimental </span>
   <span class="font10">generating </span>
   <span class="font10">granulomas </span>
   <span class="font10">induce </span>
   <span class="font10">infection, </span>
   <span class="font10">macaques </span>
   <span class="font10">mechanisms </span>
   <span class="font10">modeling </span>
   <span class="font10">mycobacterial </span>
   <span class="font10">necessary </span>
   <span class="font10">needed </span>
   <span class="font10">optimal </span>
   <span class="font10">particularly </span>
   <span class="font10">profile </span>
   <span class="font10">provided </span>
   <span class="font10">resulting </span>
   <span class="font10">review </span>
   <span class="font10">safety, </span>
   <span class="font10">selected </span>
   <span class="font10">significant </span>
   <span class="font10">strategies </span>
   <span class="font10">study, </span>
   <span class="font10">targeted </span>
   <span class="font10">vaccine. </span>
   <span class="font10">./S-()- </span>
   <span class="font10">./journal.pone. </span>
   <span class="font10">CFU </span>
   <span class="font10">Clinical </span>
   <span class="font10">EDCTP </span>
   <span class="font10">GPs </span>
   <span class="font10">HIV </span>
   <span class="font10">Health </span>
   <span class="font10">IGRA </span>
   <span class="font10">Infect </span>
   <span class="font10">Initiative </span>
   <span class="font10">M/ASE </span>
   <span class="font10">Mtb, </span>
   <span class="font10">Mtb-infected </span>
   <span class="font10">One.;():e. </span>
   <span class="font10">Phase </span>
   <span class="font10">PoI </span>
   <span class="font10">Protection </span>
   <span class="font10">R&amp;amp;D </span>
   <span class="font10">conducted </span>
   <span class="font10">dendritic </span>
   <span class="font10">funding </span>
   <span class="font10">gene </span>
   <span class="font10">induced </span>
   <span class="font10">inducing </span>
   <span class="font10">infection. </span>
   <span class="font10">key </span>
   <span class="font10">lack </span>
   <span class="font10">models, </span>
   <span class="font10">multiple </span>
   <span class="font10">play </span>
   <span class="font10">prior </span>
   <span class="font10">px; </span>
   <span class="font10">reduction </span>
   <span class="font10">relevant </span>
   <span class="font10">revaccination </span>
   <span class="font10">safe </span>
   <span class="font10">stimulate </span>
   <span class="font10">strain </span>
   <span class="font10">targeting </span>
   <span class="font10">value </span>
   <span class="font10">year </span>
   <span class="font10">{font-family </span>
   <span class="font10">Africa </span>
   <span class="font10">B-cell </span>
   <span class="font10">BCG. </span>
   <span class="font10">End </span>
   <span class="font10">European </span>
   <span class="font10">Gates </span>
   <span class="font10">ID/GLA-SE </span>
   <span class="font10">Institute </span>
   <span class="font10">M/AS </span>
   <span class="font10">MVAA </span>
   <span class="font10">Melinda </span>
   <span class="font10">Mtb-specific </span>
   <span class="font10">Respir </span>
   <span class="font10">Safety </span>
   <span class="font10">University, </span>
   <span class="font10">absence </span>
   <span class="font10">activation </span>
   <span class="font10">assessment </span>
   <span class="font10">billion </span>
   <span class="font10">children </span>
   <span class="font10">combination </span>
   <span class="font10">current </span>
   <span class="font10">developers </span>
   <span class="font10">did </span>
   <span class="font10">font-size </span>
   <span class="font10">funders </span>
   <span class="font10">generated </span>
   <span class="font10">goals </span>
   <span class="font10">guinea </span>
   <span class="font10">host </span>
   <span class="font10">identify </span>
   <span class="font10">immunotherapeutic </span>
   <span class="font10">latent </span>
   <span class="font10">level </span>
   <span class="font10">low </span>
   <span class="font10">mRNA </span>
   <span class="font10">meeting </span>
   <span class="font10">mice, </span>
   <span class="font10">months </span>
   <span class="font10">number </span>
   <span class="font10">offers </span>
   <span class="font10">overall </span>
   <span class="font10">pii: </span>
   <span class="font10">population </span>
   <span class="font10">possibility </span>
   <span class="font10">potentially </span>
   <span class="font10">predictive </span>
   <span class="font10">question </span>
   <span class="font10">receiving </span>
   <span class="font10">recently </span>
   <span class="font10">recombinant </span>
   <span class="font10">recurrence </span>
   <span class="font10">reduce </span>
   <span class="font10">regarding </span>
   <span class="font10">remains </span>
   <span class="font10">restricted </span>
   <span class="font10">reversion </span>
   <span class="font10">single </span>
   <span class="font10">spread </span>
   <span class="font10">testing </span>
   <span class="font10">therapy </span>
   <span class="font10">tissue </span>
   <span class="font10">vaccination. </span>
   <span class="font10">vaccines, </span>
   <span class="font10">virulence </span>
   <span class="font10">(%) </span>
   <span class="font10">./fimmu.. </span>
   <span class="font10">./j.tube... </span>
   <span class="font10">./j.vaccine... </span>
   <span class="font10">./journal.ppat. </span>
   <span class="font10">Africa, </span>
   <span class="font10">Calmette-Guérin </span>
   <span class="font10">Developing </span>
   <span class="font10">Development </span>
   <span class="font10">GLA-SE </span>
   <span class="font10">HLA-E </span>
   <span class="font10">Human </span>
   <span class="font10">Immun.;():–. </span>
   <span class="font10">Infection </span>
   <span class="font10">Modeling </span>
   <span class="font10">Pathog.;():e. </span>
   <span class="font10">Perspectives </span>
   <span class="font10">RUTI </span>
   <span class="font10">Vaccines: </span>
   <span class="font10">World </span>
   <span class="font10">additional </span>
   <span class="font10">administration, </span>
   <span class="font10">aerosol </span>
   <span class="font10">and/or </span>
   <span class="font10">animals </span>
   <span class="font10">annual </span>
   <span class="font10">antigenic </span>
   <span class="font10">antigens, </span>
   <span class="font10">cohort </span>
   <span class="font10">concept </span>
   <span class="font10">correlates </span>
   <span class="font10">countries </span>
   <span class="font10">design </span>
   <span class="font10">detection </span>
   <span class="font10">diverse </span>
   <span class="font10">double; </span>
   <span class="font10">field </span>
   <span class="font10">genes </span>
   <span class="font10">help </span>
   <span class="font10">immunotherapy </span>
   <span class="font10">infant </span>
   <span class="font10">invariant </span>
   <span class="font10">known </span>
   <span class="font10">ligands </span>
   <span class="font10">likely </span>
   <span class="font10">macaques, </span>
   <span class="font10">non-human </span>
   <span class="font10">occurring </span>
   <span class="font10">permitting </span>
   <span class="font10">perspective </span>
   <span class="font10">placebo-controlled </span>
   <span class="font10">positive </span>
   <span class="font10">presented </span>
   <span class="font10">product </span>
   <span class="font10">progression </span>
   <span class="font10">protect </span>
   <span class="font10">protection. </span>
   <span class="font10">published </span>
   <span class="font10">rapid </span>
   <span class="font10">received </span>
   <span class="font10">reduced </span>
   <span class="font10">released </span>
   <span class="font10">repeated </span>
   <span class="font10">reported </span>
   <span class="font10">robust </span>
   <span class="font10">set </span>
   <span class="font10">sites </span>
   <span class="font10">status </span>
   <span class="font10">sterilizing </span>
   <span class="font10">stimulating </span>
   <span class="font10">sufficient </span>
   <span class="font10">systematic </span>
   <span class="font10">targets </span>
   <span class="font10">test </span>
   <span class="font10">tools </span>
   <span class="font10">treated </span>
   <span class="font10">unconventional </span>
   <span class="font10">understanding </span>
   <span class="font10">using </span>
   <span class="font10">years. </span>
   <span class="font10">(as </span>
   <span class="font10">./ncomms </span>
   <span class="font10">B-cells </span>
   <span class="font10">CD-restricted </span>
   <span class="font10">CMV-TB </span>
   <span class="font10">Currently, </span>
   <span class="font10">DURTs </span>
   <span class="font10">HIV-infected </span>
   <span class="font10">India </span>
   <span class="font10">Moreover, </span>
   <span class="font10">Mucosal </span>
   <span class="font10">Netherlands); </span>
   <span class="font10">October </span>
   <span class="font10">Prof </span>
   <span class="font10">Public </span>
   <span class="font10">Rev.;():–. </span>
   <span class="font10">Small </span>
   <span class="font10">T-cells, </span>
   <span class="font10">TB; </span>
   <span class="font10">Ultimately, </span>
   <span class="font10">added </span>
   <span class="font10">addition </span>
   <span class="font10">adjunct </span>
   <span class="font10">adjuvant </span>
   <span class="font10">analysis </span>
   <span class="font10">averted </span>
   <span class="font10">best </span>
   <span class="font10">blood </span>
   <span class="font10">bold </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">bovis </span>
   <span class="font10">burden </span>
   <span class="font10">challenge, </span>
   <span class="font10">characterization </span>
   <span class="font10">chemotherapy </span>
   <span class="font10">collaboration </span>
   <span class="font10">completed </span>
   <span class="font10">concepts </span>
   <span class="font10">continue </span>
   <span class="font10">contributing </span>
   <span class="font10">create </span>
   <span class="font10">deleted </span>
   <span class="font10">derived </span>
   <span class="font10">despite </span>
   <span class="font10">detailed </span>
   <span class="font10">directions </span>
   <span class="font10">dissemination </span>
   <span class="font10">document </span>
   <span class="font10">dose </span>
   <span class="font10">e-. </span>
   <span class="font10">efficient </span>
   <span class="font10">efforts. </span>
   <span class="font10">emerging </span>
   <span class="font10">end </span>
   <span class="font10">enhance </span>
   <span class="font10">epidemic. </span>
   <span class="font10">established </span>
   <span class="font10">exploring </span>
   <span class="font10">expression </span>
   <span class="font10">factors </span>
   <span class="font10">field. </span>
   <span class="font10">focus </span>
   <span class="font10">follow-up </span>
   <span class="font10">gating </span>
   <span class="font10">genetically </span>
   <span class="font10">group </span>
   <span class="font10">growth </span>
   <span class="font10">increase </span>
   <span class="font10">increased </span>
   <span class="font10">indications </span>
   <span class="font10">intravenous </span>
   <span class="font10">involved </span>
   <span class="font10">leading </span>
   <span class="font10">led </span>
   <span class="font10">limited </span>
   <span class="font10">literature </span>
   <span class="font10">lymphoid </span>
   <span class="font10">macrophages </span>
   <span class="font10">mainly </span>
   <span class="font10">mathematical </span>
   <span class="font10">meaningful </span>
   <span class="font10">mediated </span>
   <span class="font10">metabolic </span>
   <span class="font10">observed </span>
   <span class="font10">obtained </span>
   <span class="font10">ongoing </span>
   <span class="font10">pipeline </span>
   <span class="font10">planned </span>
   <span class="font10">populations </span>
   <span class="font10">primary </span>
   <span class="font10">randomized, </span>
   <span class="font10">rationale </span>
   <span class="font10">reference </span>
   <span class="font10">regulatory </span>
   <span class="font10">reinfection </span>
   <span class="font10">relapse </span>
   <span class="font10">replace </span>
   <span class="font10">replacement </span>
   <span class="font10">require </span>
   <span class="font10">resistant </span>
   <span class="font10">responses. </span>
   <span class="font10">resulted </span>
   <span class="font10">routes </span>
   <span class="font10">seen </span>
   <span class="font10">serve </span>
   <span class="font10">shorten </span>
   <span class="font10">signature </span>
   <span class="font10">signatures </span>
   <span class="font10">skin </span>
   <span class="font10">solid; </span>
   <span class="font10">species </span>
   <span class="font10">specifically </span>
   <span class="font10">stage-gate </span>
   <span class="font10">strain, </span>
   <span class="font10">strategic </span>
   <span class="font10">strong </span>
   <span class="font10">successful </span>
   <span class="font10">suggests </span>
   <span class="font10">techniques </span>
   <span class="font10">tomography </span>
   <span class="font10">transfer </span>
   <span class="font10">transmission </span>
   <span class="font10">types </span>
   <span class="font10">ultimately </span>
   <span class="font10">underway </span>
   <span class="font10">unvaccinated </span>
   <span class="font10">vaccination, </span>
   <span class="font10">vaccine-induced </span>
   <span class="font10">vector </span>
   <span class="font10">working </span>
   <span class="font10">years </span>
   <span class="font10">young </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Edinb).;:–. </span>
   <span class="font10">(University </span>
   <span class="font10">.%, </span>
   <span class="font10">./IAI.- </span>
   <span class="font10">./imr. </span>
   <span class="font10">AIDS </span>
   <span class="font10">Alternative </span>
   <span class="font10">Animal </span>
   <span class="font10">BCG-vaccinated </span>
   <span class="font10">Barry </span>
   <span class="font10">China, </span>
   <span class="font10">Controlled </span>
   <span class="font10">Countries </span>
   <span class="font10">Cytomegalovirus </span>
   <span class="font10">ESAT- </span>
   <span class="font10">Experiments </span>
   <span class="font10">General </span>
   <span class="font10">Geneva, </span>
   <span class="font10">IFN-γ </span>
   <span class="font10">IVE-TB </span>
   <span class="font10">Initiative, </span>
   <span class="font10">International </span>
   <span class="font10">Kaufmann) </span>
   <span class="font10">LAVs </span>
   <span class="font10">Maryland, </span>
   <span class="font10">Mathematical </span>
   <span class="font10">Preclinical </span>
   <span class="font10">Progress </span>
   <span class="font10">Research </span>
   <span class="font10">Results </span>
   <span class="font10">Review </span>
   <span class="font10">RhCMV-TB </span>
   <span class="font10">Role </span>
   <span class="font10">Serum </span>
   <span class="font10">Stage </span>
   <span class="font10">Stop </span>
   <span class="font10">Strategy </span>
   <span class="font10">Studies </span>
   <span class="font10">T-Cell </span>
   <span class="font10">TB: </span>
   <span class="font10">Trials </span>
   <span class="font10">UK); </span>
   <span class="font10">Vaccae™ </span>
   <span class="font10">accelerate </span>
   <span class="font10">acceptable </span>
   <span class="font10">activity </span>
   <span class="font10">adaptive </span>
   <span class="font10">adjunctive </span>
   <span class="font10">adjuvanted </span>
   <span class="font10">administer </span>
   <span class="font10">advanced </span>
   <span class="font10">agent </span>
   <span class="font10">animals, </span>
   <span class="font10">appear </span>
   <span class="font10">appears </span>
   <span class="font10">arm </span>
   <span class="font10">attempting </span>
   <span class="font10">bacille </span>
   <span class="font10">balance </span>
   <span class="font10">biological </span>
   <span class="font10">biosignature </span>
   <span class="font10">blood, </span>
   <span class="font10">breadth </span>
   <span class="font10">candidates, </span>
   <span class="font10">care </span>
   <span class="font10">challenge. </span>
   <span class="font10">common </span>
   <span class="font10">completion </span>
   <span class="font10">concerns </span>
   <span class="font10">conducting </span>
   <span class="font10">continuous </span>
   <span class="font10">contribute </span>
   <span class="font10">correlate </span>
   <span class="font10">courier; </span>
   <span class="font10">course </span>
   <span class="font10">creating </span>
   <span class="font10">cured </span>
   <span class="font10">cynomolgus </span>
   <span class="font10">day </span>
   <span class="font10">decline </span>
   <span class="font10">deletions </span>
   <span class="font10">deliver </span>
   <span class="font10">described </span>
   <span class="font10">designed </span>
   <span class="font10">detect </span>
   <span class="font10">detected </span>
   <span class="font10">determined </span>
   <span class="font10">development, </span>
   <span class="font10">diagnostics </span>
   <span class="font10">differ </span>
   <span class="font10">directed </span>
   <span class="font10">doses </span>
   <span class="font10">double-blind, </span>
   <span class="font10">driving </span>
   <span class="font10">drug-sensitive </span>
   <span class="font10">effector </span>
   <span class="font10">efficacious </span>
   <span class="font10">elicit </span>
   <span class="font10">em; </span>
   <span class="font10">endpoint </span>
   <span class="font10">enhanced </span>
   <span class="font10">enrolled </span>
   <span class="font10">entering </span>
   <span class="font10">essential </span>
   <span class="font10">estimated </span>
   <span class="font10">evaluate </span>
   <span class="font10">evidence, </span>
   <span class="font10">example </span>
   <span class="font10">expected </span>
   <span class="font10">experiments. </span>
   <span class="font10">explore </span>
   <span class="font10">exposure, </span>
   <span class="font10">exposures </span>
   <span class="font10">expressing </span>
   <span class="font10">facilitate </span>
   <span class="font10">far </span>
   <span class="font10">finding </span>
   <span class="font10">focused </span>
   <span class="font10">gate </span>
   <span class="font10">higher </span>
   <span class="font10">humoral </span>
   <span class="font10">identifying </span>
   <span class="font10">immunisation </span>
   <span class="font10">immunity, </span>
   <span class="font10">incidence </span>
   <span class="font10">induction </span>
   <span class="font10">infectious </span>
   <span class="font10">introduction </span>
   <span class="font10">involves </span>
   <span class="font10">involving </span>
   <span class="font10">issues </span>
   <span class="font10">laboratory </span>
   <span class="font10">large </span>
   <span class="font10">latently </span>
   <span class="font10">later </span>
   <span class="font10">little </span>
   <span class="font10">live </span>
   <span class="font10">long </span>
   <span class="font10">lung, </span>
   <span class="font10">macrophage </span>
   <span class="font10">maintain </span>
   <span class="font10">management </span>
   <span class="font10">manipulated </span>
   <span class="font10">manner </span>
   <span class="font10">manufacturing </span>
   <span class="font10">million </span>
   <span class="font10">models. </span>
   <span class="font10">molecules </span>
   <span class="font10">monoclonal </span>
   <span class="font10">multidrug </span>
   <span class="font10">murine </span>
   <span class="font10">naturally </span>
   <span class="font10">near-sterilizing </span>
   <span class="font10">negative </span>
   <span class="font10">numbers </span>
   <span class="font10">occurred </span>
   <span class="font10">outcome </span>
   <span class="font10">partners </span>
   <span class="font10">people </span>
   <span class="font10">period </span>
   <span class="font10">peripheral </span>
   <span class="font10">pigs </span>
   <span class="font10">placebo </span>
   <span class="font10">political </span>
   <span class="font10">polyfunctional </span>
   <span class="font10">populations, </span>
   <span class="font10">post-exposure </span>
   <span class="font10">predict </span>
   <span class="font10">present </span>
   <span class="font10">previously </span>
   <span class="font10">primarily </span>
   <span class="font10">priming </span>
   <span class="font10">priorities </span>
   <span class="font10">process </span>
   <span class="font10">profiles </span>
   <span class="font10">promising </span>
   <span class="font10">proof </span>
   <span class="font10">properties </span>
   <span class="font10">providing </span>
   <span class="font10">pt;} </span>
   <span class="font10">randomized </span>
   <span class="font10">rates </span>
   <span class="font10">reactivation </span>
   <span class="font10">receptors </span>
   <span class="font10">recognition </span>
   <span class="font10">reducing </span>
   <span class="font10">required </span>
   <span class="font10">resources </span>
   <span class="font10">restriction </span>
   <span class="font10">revealed </span>
   <span class="font10">samples </span>
   <span class="font10">second </span>
   <span class="font10">sensitivity </span>
   <span class="font10">serum </span>
   <span class="font10">shown </span>
   <span class="font10">specimens </span>
   <span class="font10">stages </span>
   <span class="font10">standard </span>
   <span class="font10">state </span>
   <span class="font10">studies, </span>
   <span class="font10">studies. </span>
   <span class="font10">sub-Saharan </span>
   <span class="font10">subsequent </span>
   <span class="font10">sufficiently </span>
   <span class="font10">that, </span>
   <span class="font10">trials, </span>
   <span class="font10">tuberculosis: </span>
   <span class="font10">understand </span>
   <span class="font10">utilized </span>
   <span class="font10">various </span>
   <span class="font10">vectors </span>
   <span class="font10">viable </span>
   <span class="font10">vivo </span>
   <span class="font10">way </span>
   <span class="font10">widely </span>
   <span class="font10">work </span>
   <span class="font10">years, </span>
  </p>
 </body>
</html>
